Dario Scimeca

Company: Precision BioSciences

Job title: General Counsel

Seminars:

Panel Discussion: Addressing Concerns Over Cuts to FDA, NIH, CDC & CMS: What it Means for Innovation, Compliance & Talent Retention 9:30 am

How cuts to agencies like FDA, NIH, CMS, and CDC may delay approvals, complicate drug development, and hinder access to government-supported programs How uncertainty fuels tension between legal teams and commercial functions Navigate a shifting regulatory environment amid “brain drain,” reassignment, and ambiguity around enforcement priorities at agencies including DOJRead more

day: Day 1

Fireside Chat: Moving Beyond IPOs & Exploring Alternative Financing Strategies to Secure Biopharma Growth 11:30 am

Why more biopharma companies are reconsidering IPOs amid 2025’s market volatility and political uncertainty Understand alternative models: private equity, venture debt, royalty financing, and strategic partnerships Legal and operational challenges in structuring non-IPO financing to drive sustainable long-term growthRead more

day: Day 1

Panel Discussion: What Legal Teams Need to Know About Raising Capital in an Uncertain Market 2:00 pm

How are investors evaluating biopharma opportunities in today’s economic climate? Legal risks and compliance challenges in securing funding amid financial uncertainty Practical strategies for legal teams to support successful fundraising effortsRead more

day: Day 1